Ranbaxy launches Augmentin clone in US
Ranbaxy Laboratories has launched the generic version of GlaxoSmithkline's blockbuster antibiotic, Augmentin, in the US. Ranbaxy is the fourth company to have launched the generic version of the $2
Ranbaxy Laboratories has launched the generic version of GlaxoSmithkline's blockbuster antibiotic, Augmentin, in the US. Ranbaxy is the fourth company to have launched the generic version of the $2